Clinical medicine profile
Proteins Supplement / Potassium Supplement
Therapeutic agent (verify pharmacological class)
- Route
- See product SmPC
- Schedule
- POM
- ATC
- Not assigned
- PPB status
- registered
This profile needs source confirmation
A traceable source link is not attached to this profile. Confirm prescribing decisions against the current SmPC and Kenya STG/EML.
Safety essentials
The information most likely to change a prescribing or dispensing decision.
Contraindications
- [Proteins Supplement] Hypersensitivity to the active substance or excipients.
- Additional absolute contraindications are indication- and product-specific — consult SmPC.
Precautions
- The loss of fluid accompanied by the use of potassium supplements can cause renal toxicity
- conditions that can cause delay absorption of potassium can cause or worsen GIT irritation
- conditions predisposing to hyperkalaemia, such as acute metabolic acidosis, adrenal insufficiency, acute dehydration, and uncontrolled diabetes mellitus.
Dosing matrix
Population and organ-function guidance, shown together for faster comparison.
Prophylaxis: 2-3 tabs daily. Correction: 5-6[up to 12] daily.
See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.
Review renal impairment dosing; many agents need CrCl/eGFR adjustment.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.
Use, effects & interactions
Indications
- Treatment and prophylaxis of hypokalaemia
- metabolic alkalosis
- in chronic digitalis intoxication
- hypokalaemic familial periodic paralysis
- those on potassium-depleting drugs like thiazides and loop diuretics
- hepatic cirrhosis with ascites
- in chronic and secondary hyperaldosteronism
- chronic diarrhoea
- chronic laxative use
- prolonged vomiting
- long-term corticosteroid therapy
- potassium losing nephropathy
Adverse effects
- Adverse reactions vary by agent.
- Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes).
- Report suspected ADRs via national pharmacovigilance channels.
Drug interactions
Open multi-drug checker ↗- Fixed-dose/multi-ingredient product.
- Clinical details partially inherited from component monographs: Proteins Supplement / Potassium Supplement.
- Confirm combination SmPC for exact dosing.
Mechanism & disposition
It is the main intracellular cati-on.
Read complete mechanism
It is the main intracellular cati-on. Na+K+ATPase actively pumps sodium out and potassium into cells to maintain these concentra-tion gradients. These potassium concentration gradients are necessary for the conduction of nerve impulses it the heart, brain, and skeletal muscle, and for the maintenance of normal renal function and acid-base balance. High intracellular potassium concentrations are necessary for numerous cellular metabolic processes.
Product-specific
Product-specific
See product SmPC
are product-specific. Consider food effects, protein binding, hepatic CYP/UGT
when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.
Pregnancy, lactation & diet
Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.
Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.
Brands & loaded prices
| Brand | Manufacturer | Pack | Observed price |
|---|---|---|---|
| No reviewed brand listings are linked yet. | |||
Sources & review state
Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.